Neutrophil gene expression in chronic myeloproliferative disorders.

被引:0
|
作者
Eagleton, HJ [1 ]
Pellagatti, A [1 ]
Campbell, L [1 ]
Littlewood, TJ [1 ]
Wainscoat, JS [1 ]
Boultwood, J [1 ]
机构
[1] John Radcliffe Hosp, LRF Mol Haematol Unit, Oxford OX3 9DU, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4488
引用
收藏
页码:192B / 192B
页数:1
相关论文
共 50 条
  • [31] Neutrophil and eosinophil PRV-1 expression in atypical myeloproliferative disorders
    Sirhan, S
    Lasho, TL
    Elliott, MA
    Tefferi, A
    BLOOD, 2004, 104 (11) : 426A - 426A
  • [32] CALCITONIN-GENE METHYLATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS
    IHALAINEN, J
    JUVONEN, E
    SAVOLAINEN, ER
    RUUTU, T
    PALOTIE, A
    LEUKEMIA, 1994, 8 (02) : 230 - 235
  • [33] Thrombopoietin expression and plasma concentrations in chronic myeloproliferative disorders
    Tefferi, A
    LEUKEMIA RESEARCH, 2003, 27 (02) : 121 - 123
  • [34] Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders
    Passamonti, F
    Pietra, D
    Malabarba, L
    Rumi, E
    Porta, MGD
    Malcovati, L
    Bonfichi, M
    Pascutto, C
    Lazzarino, M
    Cazzola, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (05) : 650 - 656
  • [35] Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders
    Duensing, S
    Duensing, A
    Meran, JG
    Kreft, A
    Büsche, G
    Ganser, A
    Georgii, A
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1999, 52 (03): : 146 - 150
  • [36] Chronic myeloproliferative disorders
    de Ozalla, CBA
    Suárez, JG
    REVISTA CLINICA ESPANOLA, 1999, 199 : 28 - 36
  • [37] Platelet surface P-selectin in myeloproliferative disorders.
    Cacciola, E
    Cacciola, RR
    Stagno, F
    Giustolisi, R
    BLOOD, 1998, 92 (10) : 255B - 255B
  • [38] Dynamics of Telomere Length and Telomerase Activity in Ph1 - Negative Chronic Myeloproliferative Disorders.
    Bazdiara, Ioanna
    Pantelidou, Despina
    Anastasiadis, Athanasios
    Papadopoulos, Vassilios
    Margaritis, Dirnitrios
    Spanoudakis, Emmanouil
    Xanthopoulidis, Georgios
    Kotsianidis, Loannis
    Christoforidou, Anna
    Goutzouvelidis, Aggelos
    Bourikas, Georgios
    Tsatalas, Konstantinos
    BLOOD, 2008, 112 (11) : 963 - 964
  • [39] High prevalence of moderate hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders.
    Faurschou, M
    Nielsen, OJ
    Hasselbalch, HC
    BLOOD, 1999, 94 (10) : 111A - 111A
  • [40] JAK2 mutation in granulocytes and platelets and X-chromosome gene-based clonal analysis in chronic myeloproliferative disorders.
    Toyama, Kohtaro
    Tsukamoto, Norifurni
    Hiroyuki, Irisawa
    Yokohama, Akihiko
    Saitoh, Takayuki
    Handa, Hiroshi
    Matsushima, Takafumi
    Murakami, Hirokazu
    Miyawaki, Shuichi
    Nojima, Yoshihisa
    Karasawa, Masamitsu
    BLOOD, 2006, 108 (11) : 310B - 310B